Abstract:Pooled genetic screens are powerful tools to study gene function in a high-throughput manner. Typically, sequencing-based screens require cell lysis, which limits the examination of critical phenotypes such as cell morphology, protein subcellular localization, and cell-cell/tissue interactions. In contrast, emerging optical pooled screening methods enable the investigation of these spatial phenotypes in response to targeted CRISPR perturbations. In this study, we report a multi-omic optical pooled CRISPR screening method, which we have named CRISPRmap. Our method combines a novel in situ CRISPR guide identifying barcode readout approach with concurrent multiplexed immunofluorescence and in situ RNA detection. CRISPRmap barcodes are detected and read out through combinatorial hybridization of DNA oligos, enhancing barcode detection efficiency, while reducing both dependency on third party proprietary sequencing reagents and assay cost. Notably, we conducted a multi-omic base-editing screen in a breast cancer cell line on core DNA damage repair genes involved in the homologous recombination and Fanconi anemia pathways investigating how nucleotide variants in those genes influence DNA damage signaling and cell cycle regulation following treatment with ionizing radiation or DNA damaging agents commonly used for cancer therapy. Approximately a million cells were profiled with our multi-omic approach, providing a comprehensive phenotypic assessment of the functional consequences of the studied variants. CRISPRmap enabled us to pinpoint likely-pathogenic patient-derived mutations that were previously classified as variants of unknown clinical significance. Furthermore, our approach effectively distinguished barcodes of a pooled library in tumor tissue, and we coupled it with cell-type and molecular phenotyping by cyclic immunofluorescence. Multi-omic spatial analysis of how CRISPR-perturbed cells respond to various environmental cues in the tissue context offers the potential to significantly expand our understanding of tissue biology in both health and disease.

Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap

CRISPRmap: Sequencing-free optical pooled screens mapping multi-omic phenotypes in cells and tissue

Multimodal optical pooled screening with CRISPRmap

Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System

Genetic and Pharmacological Interrogation of Cancer Vulnerability Using a Multiplexed Cell Line Screening Platform

Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution

High-content imaging-based pooled CRISPR screens in mammalian cells

Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing

A genome-scale single cell CRISPRi map of trans gene regulation across human pluripotent stem cell lines

Spatially Resolved in vivo CRISPR Screen Sequencing via Perturb-DBiT

Linking Genotypes with Multiple Phenotypes in Single-Cell CRISPR Screens

CRISPR-StAR enables high-resolution genetic screening in complex in vivo models

High-resolution characterization of gene function using single-cell CRISPR tiling screen

Large-scale multiplexed mosaic CRISPR perturbation in the whole organism

Pooled Genome-Scale CRISPR Screens in Single Cells

CROPseq-multi: a versatile solution for multiplexed perturbation and decoding in pooled CRISPR screens

Multiplexed, Image-Based Pooled Screens in Primary Cells and Tissues with PerturbView

Precise measurement of molecular phenotypes with barcode-based CRISPRi systems

Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics

High-content CRISPR screening

Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements